HorbergMA, HurleyLB, KleinDB, et al.The HIV care cascade measured over time and by age, sex, and race in a large national integrated care system. AIDS Patient Care STDs, 2015; 29:582–590.
2.
SeibertB. Ready to look back and remember. New York Times, October9, 2016.
3.
GalloRC. Point of view: AIDS as a clinically curable disease: The growing optimism. AIDS Patient Care STDs, 1996; 10:7–9.
4.
RodgerJA, LodwickR, MauroS, et al.Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS, 2013; 27:973–979.
5.
LaurenceJ. Seeking a cure for AIDS. The AIDS Reader, 2008; 18:228.
6.
HütterG, NowakD, MossnerM, et al.Treatment of HIV-1 infection by allogeneic CCR5-Δ32/Δ32 stem cell transplantation: A promising approach. 15th Conference on Retroviruses and Opportunistic Infections, Boston, MA, February 3–6, 2008, Abst. 719.
7.
WoodhamAW, SkeateJG, SannaAM, et al.Human immunodeficiency virus immune cell receptors, coreceptors, and cofactors: Implications for prevention and treatment. AIDS Patient Care STDs, 2016; 30:291–306.
8.
CostiniukCT, JenebianM-A. HIV reservoir dynamics in the face of highly active antiretroviral therapy. AIDS Patient Care STDs, 2015; 29:55–68.
9.
LedermanMM, CannonPM, CurrierJS, et al.A cure for HIV infection: “Not in my lifetime” or “Just around the corner”?. Pathog Immun, 2016; 1:154–164.
10.
SchoofsM. A doctor, a mutation, and a potential cure for AIDS. Wall Street Journal, November7, 2008.
11.
HütterG, BodorJ, LedgerS, et al.CCR5 targeted cell therapy for HIV and prevention of viral escape. Viruses, 2015; 7:4186–4203
12.
LoY-R, ChuC, AnanworanichJ, ExclerJ-L, TuckerJD. Stakeholder engagement in HIV cure research: Lessons learned from other HIV interventions and the way forward. AIDS Patient Care STDs, 2015; 29:389–399.
13.
WangJ, HolmesMC. Engineering hematopoietic stem cells toward a functional cure of human immunodeficiency virus infection. Cytotherapy, 2016; 18:1370–1381.
